Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
PainChek
Healthcare Stocks Life Sciences
PainChek (ASX:PCK): Investors dreamed 2025 would be the year it finally enters the US market, and their dreams are becoming a reality!
PainChek (ASX:PCK) has among the most admirable medical technologies there is, in the form of an app that can detect pain in non-verbal patients. Unfortunately, there has been pain for investors along the way. When it was announced that it was participating in a clinical trial the Morrison government was investing $5m in back in 2019,…
October 8, 20250Comments
Cyclopharm
Healthcare Stocks Life Sciences Small Caps Stocks Tech Stocks Technology
Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism
Cyclopharm (ASX:CYC) is a rare species - an ASX stock that is approved in the US market. However, its share price has gone in the opposite direction. Cyclopharm has not had as fast an uplift as other companies have had and still makes most of its sales from other jurisdictions. A lawsuit from 4D Medical…
October 8, 20250Comments
activist investors
Agriculture Stocks AI Stocks Airlines Bank Stocks Basic Materials Biotech Stocks Blue Chip Stocks Cannabis Stocks CleanTech Coal Stocks Cobalt Stocks Consumer Copper Stocks Cryptocurrencies Currency Currency Forecast Cybersecurity Stocks Defence Stocks Dividend Stocks Education Education Stocks Energy Stocks ETF EV Stocks Financials Gaming Stocks General Gold Stocks Graphite Stocks Green Investments Growth Stocks Healthcare Stocks Index Funds Industrials International Stocks IPOs Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Market news Mid Cap Stocks Mining Stocks News Nickel Stocks Oil and Gas Stocks Palladium Stocks Penny Stocks Property Rare Earths Stocks Real Estate Resources Retail Safe Stocks Semiconductor stocks Silver stocks Small Caps Stocks Steel Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks Uncategorized Undervalued Stocks Uranium Stocks Vanadium Stocks
Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for
Hear the term 'Activist investors' and you might think of GetUp, the progressive activist group that forced Woolworths to hold an EGM in 2014 in an attempt to limit the maximum bets on poker machines to $1. Or perhaps even of ESG-focused fundies like Australian Ethical (ASX:AEF). The reality is a lot more complicated and…
October 8, 20250Comments
peninsula energy
Mining Stocks Resources Uranium Stocks
Peninsula Energy (ASX:PEN): It was arguably the ASX best uranium play, but 2025 was an annus horribilus
This week we are taking an in-depth look at Peninsula Energy (ASX:PEN). It is one of a handful of uranium stocks that are re-starting mothballed projects after a prolonged period of downward prices. But a number of issues meant that 2025 has been a difficult for the company with a number of operational issues meaning its…
October 8, 20250Comments
Robex
Gold Stocks Mid Cap Stocks Mining Stocks Small Caps Stocks
Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) are merging to become a major gold miner; but is West Africa too risky?
On Monday October 6 2025, whilst NSW and Queensland were on holiday, Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) investors were informed of the news that their companies would be merging. Both companies were already well-positioned companies with individual gold mines that were amongst the lowest cost and most advanced. But this merger puts both companies in…
October 7, 20250Comments
Pepper Money
Bank Stocks Consumer Small Caps Stocks
Pepper Money (ASX:PPM): Flexibility is better…if you’re a borrower but what if you’re an investor?
Pepper Money's (ASX:PPM) promise to borrowers has been flexibility. You may not be 'good enough' to match the Big Banks' standards, but Pepper might be able to help. It had a >20 year history prior to its mid-2021 listing where it raised $500m at $2.89 per share, implying an A$1.3bn market capitalisation. And it has…
October 6, 20250Comments
Southern Cross Seven West Media Merger
Blue Chip Stocks Consumer Large Caps Market news Mid Cap Stocks
Why Do Investors Hate the Southern Cross Seven West Media Merger? Here are 6 reasons why
Ever since the Southern Cross Seven West Media Merger was announced back on Tuesday (September 30), it has been met with disappointment at best, anger and disgust at worst. What's not to like? A pair of media companies are teaming up to give the best chance of survival in a highly competitive industry being disrupted by…
October 3, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here